Tempus AI’s (TEM) “Neutral” Rating Reaffirmed at Piper Sandler

Tempus AI (NASDAQ:TEM)‘s stock had its “neutral” rating restated by investment analysts at Piper Sandler in a research report issued on Tuesday,Benzinga reports. They currently have a $70.00 price objective on the stock, up from their previous price objective of $40.00. Piper Sandler’s price target would indicate a potential upside of 2.82% from the company’s previous close.

TEM has been the topic of a number of other reports. Needham & Company LLC reaffirmed a “buy” rating and issued a $47.00 target price on shares of Tempus AI in a report on Wednesday, August 7th. Stifel Nicolaus cut Tempus AI from a “buy” rating to a “hold” rating and raised their target price for the stock from $45.00 to $65.00 in a report on Monday. JPMorgan Chase & Co. raised their target price on Tempus AI from $42.00 to $47.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Bank of America cut Tempus AI from a “buy” rating to a “neutral” rating and raised their target price for the stock from $45.00 to $60.00 in a report on Wednesday, October 2nd. Finally, Loop Capital raised their target price on Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a report on Tuesday, October 15th. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $54.22.

Tempus AI Trading Up 0.1 %

Shares of TEM opened at $68.08 on Tuesday. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The company’s fifty day moving average is $51.19. Tempus AI has a 1-year low of $22.89 and a 1-year high of $79.49.

Institutional Investors Weigh In On Tempus AI

A number of institutional investors and hedge funds have recently bought and sold shares of TEM. First Horizon Advisors Inc. purchased a new position in shares of Tempus AI during the third quarter valued at about $30,000. Sandia Investment Management LP purchased a new position in shares of Tempus AI during the second quarter valued at about $136,000. Vestor Capital LLC purchased a new position in shares of Tempus AI during the third quarter valued at about $153,000. IQ EQ FUND MANAGEMENT IRELAND Ltd purchased a new position in shares of Tempus AI during the third quarter valued at about $258,000. Finally, Clarus Group Inc. purchased a new position in shares of Tempus AI during the third quarter valued at about $283,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.